Position
Chief Executive Officer
Company
Expression Therapeutics
AtlantaBiotechnologyHealth CareTherapeuticsBiopharmaDescription
Expression Therapeutics, Inc has appointed David F. Townson as Chief Executive Officer, effective immediately. Dr Townson brings significant executive leadership experience from Pfizer, Novartis, and Bayer in advancing transformative oncology and cell therapy programs.
Quick answer
Expression Therapeutics Appoints David F. Townson as Chief Executive Officer (December 10, 2025). Expression Therapeutics is based in Atlanta, Georgia, United States.
- Who is the new Chief Executive Officer at Expression Therapeutics?
- Expression Therapeutics named David F. Townson Chief Executive Officer, announced December 10, 2025.
- What did Expression Therapeutics announce on December 10, 2025?
- Expression Therapeutics, Inc has appointed David F. Townson as Chief Executive Officer, effective immediately. Dr Townson brings significant executive leadership experience from Pfizer, Novartis, and Bayer in advancing transformative oncology and cell therapy programs.
- What does Expression Therapeutics do?
- Expression Therapeutics, Inc., based in Atlanta, Georgia, is a clinical-stage biotechnology company pioneering a curative gene therapy for hemophilia A and best-in-class cell therapies for neuroendocrine tumors (NETs)...
- Where is Expression Therapeutics based?
- Expression Therapeutics is based in Atlanta, Georgia, United States.
- Which similar companies made leadership changes around the same time?
- Centessa Pharmaceuticals plc (December 12, 2025), Ichnos Glenmark Innovation (December 4, 2025), Sudo Biosciences (December 4, 2025) and Gilead Sciences (December 18, 2025) also announced leadership changes within 45 days of Expression Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biopharma
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Centessa Pharmaceuticals Appoints Mario Alberto Accardi as CEO (December 12, 2025)
- Ichnos Glenmark Innovation Appoints Lida Pacaud as Interim Chief Executive Officer (December 4, 2025)
- Sudo Biosciences Appoints Paul Bavier as Chief Legal Officer (December 4, 2025)
- Gilead Sciences Appoints Keeley Wettan as Executive Vice President, General Counsel (December 18, 2025)
- Jubilant Pharmova Appoints Daniel J. O’Connor as Chief Executive Officer (December 2, 2025)
- Vistagen Appoints Nick Tressler as Chief Financial Officer (December 1, 2025)
Who to call at Expression Therapeutics, and when
A new leader at Expression Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Expression Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Expression Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Expression Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Expression Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Expression Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.